Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The European Union Horizon Europe (with joint funding from UK Research Innovation) has awarded NetZeroAICT Consortium major funding to develop a novel technology with great potentials to promote climate neutral and sustainable health care.

NetZero scientists croup with green T-shirts © NetZeroAICT

This International Transdisciplinary Consortium is led by Professor Regent Lee at Oxford University’s Nuffield Department of Surgical sciences. He is a UK Research Innovation Future Leaders Fellow and Associate Professor of Vascular Surgery. The Oxford team further includes Professor Vicente Grau, Professor of Engineering Science at the Institute of Biomedical Engineering. Their team developed the pioneering technology (CT Digital Contrast) which can make Computerised Tomography (CT) scans safer, faster, more equitable and more sustainable.

The Horizon Europe award funding (total of €6M) will accelerate scientific development, clinical validation and subsequent regulatory approval of CT Digital Contrast. It will harness the comprehensive collective expertise of the 20 partners across academia, healthcare and industry.

 

Read the full story on the Nuffield Department of Surgical Sciences website.

Similar stories

Typhoid vaccine trial confirms sustained protection for older children

A single dose of typhoid conjugate vaccine (TCV) offers safe, effective protection against typhoid two years after vaccination in all children, and sustained protection for older children at three to five years post immunisation, according to a report by researchers at the Oxford Vaccine Group and the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b). But it also shows a decline in protection at the later timepoints among children vaccinated at younger ages.